Cardiff Oncology (NASDAQ:CRDF) Earns "Buy" Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Pennsylvania-headquartered Helius Medical Technologies, Inc. (HSDT) is up over 51% in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.
Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Cardiff Oncology to post earnings of ($0.25) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Cardiff Oncology (NASDAQ:CRDF […]